Self-expanding metal stents have, when introduced in their constrained form
through gastrointestinal and biliary strictures, a relatively small diamet
er. Once placed through the stricture and released, however, they expand to
a much larger internal diameter, thus giving rise to sufficient palliative
reopening of these strictures. Since metal stents are usually not removabl
e, their primary use has been in malignant stenoses. Benign strictures shou
ld be treated with metal stents only in exceptional situations. For palliat
ion of dysphagia in esophagocardial malignancies, metal stents have been sh
own to be associated with significantly fewer initial complications on plac
ement than plastic tubes. The long-term fate of both stent types seems to b
e similar. In the palliation of malignant jaundice, metal stents were demon
strated to have a significantly longer patency rate, resulting in a favoura
ble cost-benefit ratio despite the high price of metal stents. Continued de
velopments are necessary to further reduce long-term complications and effe
ctiveness.